1. Home
  2. ATAI vs KGEI Comparison

ATAI vs KGEI Comparison

Compare ATAI & KGEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • KGEI
  • Stock Information
  • Founded
  • ATAI 2018
  • KGEI 2008
  • Country
  • ATAI Germany
  • KGEI United States
  • Employees
  • ATAI N/A
  • KGEI N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • KGEI
  • Sector
  • ATAI Health Care
  • KGEI
  • Exchange
  • ATAI Nasdaq
  • KGEI Nasdaq
  • Market Cap
  • ATAI 444.7M
  • KGEI 254.9M
  • IPO Year
  • ATAI 2021
  • KGEI N/A
  • Fundamental
  • Price
  • ATAI $4.61
  • KGEI $5.83
  • Analyst Decision
  • ATAI Strong Buy
  • KGEI Strong Buy
  • Analyst Count
  • ATAI 3
  • KGEI 1
  • Target Price
  • ATAI $13.33
  • KGEI $11.00
  • AVG Volume (30 Days)
  • ATAI 4.7M
  • KGEI 82.4K
  • Earning Date
  • ATAI 11-12-2025
  • KGEI 11-11-2025
  • Dividend Yield
  • ATAI N/A
  • KGEI N/A
  • EPS Growth
  • ATAI N/A
  • KGEI 35.27
  • EPS
  • ATAI N/A
  • KGEI 0.54
  • Revenue
  • ATAI $2,309,000.00
  • KGEI $57,936,000.00
  • Revenue This Year
  • ATAI $712.99
  • KGEI $14.07
  • Revenue Next Year
  • ATAI N/A
  • KGEI $26.69
  • P/E Ratio
  • ATAI N/A
  • KGEI $10.83
  • Revenue Growth
  • ATAI 510.85
  • KGEI 6.52
  • 52 Week Low
  • ATAI $1.03
  • KGEI $2.91
  • 52 Week High
  • ATAI $5.34
  • KGEI $9.89
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 57.88
  • KGEI 57.38
  • Support Level
  • ATAI $4.50
  • KGEI $5.03
  • Resistance Level
  • ATAI $4.75
  • KGEI $5.45
  • Average True Range (ATR)
  • ATAI 0.28
  • KGEI 0.20
  • MACD
  • ATAI -0.04
  • KGEI 0.07
  • Stochastic Oscillator
  • ATAI 50.33
  • KGEI 66.12

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About KGEI Kolibri Global Energy Inc. Common stock

Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. The company derives a majority of its revenue from the United States.

Share on Social Networks: